Introduction {#Sec1}
============

Plant cell and tissue culture uses nutritive culture media and controlled aseptic conditions for the growth of plant cells, tissues and organs. Since its first establishment by Haberlandt in the early twentieth century, this type of culture has evolved into an essential tool for plant research at both the basic and applied levels (Haberlandt [@CR66]). In vitro culture techniques are now indispensable for the production of disease-free plants, rapid multiplication of rare plant genotypes, plant genome transformation, and production of plant-derived metabolites of important commercial value (see Fig. [1](#Fig1){ref-type="fig"}) (Debnarh et al. [@CR37]; Altpeter et al. [@CR6]).Fig. 1Diagram of current methods employed for the large-scale production of bioactive compounds using plant in vitro tissue culture

Due to the diversity of the methods and applications of available culture techniques, the subject of plant cell/tissue culture is extensively covered in the existing literature. Some works have even focused on the use of in vitro tissue culture for the production of secondary metabolites (Verpoorte et al. [@CR172], [@CR173]; Smetanska [@CR156]; Karuppusamy [@CR80]). This work aims to provide an updated overview on the use of in vitro culture for the production of medicinally or commercially important plant metabolites and bioengineered products, nevertheless because of the ample range of information available not all works within the scope of the article could be included, we apologize to those authors. The objective of this review is, therefore, to summarize the main molecules currently being produced using plant cell/tissue culture, their applications in areas such as medicine and food technology, and the plant material cultured for their production. The review also covers new trends in in vitro cell/tissue culture and plant transformation.

Production of biologically active compounds {#Sec2}
===========================================

Secondary metabolites {#Sec3}
---------------------

The term secondary metabolite refers to a compound produced by plants, microorganisms or animals that is not required for their growth (Pickens et al. [@CR127]). Humans have long used the products of plant secondary metabolism to satisfy a multitude of different needs (Borchardt [@CR21]; Patwardhan [@CR123]; Cragg and Newman [@CR34]). The primary use of these compounds has been as medicinal agents, first in an empirical way and subsequently, starting in the 19th century, in a more rational way following the advent of molecule isolation (Corson and Crews [@CR33]; Zenk and Juenger [@CR190]; Cragg and Newman [@CR34]). Despite the extensive research into secondary metabolites over such a long period of time, current estimates indicate that only about 6% of higher plants (between 300,000 and 500,000 species) have been systematically studied for their pharmacological potential, and only 15% have been evaluated for phytochemicals in general (Fabricant and Farnsworth [@CR46]; Cragg and Newman [@CR34]). Therefore, enormous opportunities exist for continued studies in this field.

The identification and isolation of a useful bioactive compound immediately generates a need for a method for its continuous production. A secondary metabolite is typically characterized by its diverse and complex chemical structure, usually encompassing multiple chiral centers and labile bonds, and this makes its chemical synthesis challenging (Pickens et al. [@CR127]). Therefore, biologically active molecules are more commonly extracted from their natural sources. However, since most of the source plants are wild rather than domesticated species, harvesting from their natural habitats presents a risk of overexploitation, as well as creating a bottleneck in the production of the compounds. Further complications include the slow growth rates of many source plants, the low concentrations of the active compounds of interest and, frequently, the need for biotic or abiotic stress to induce biosynthesis. All these factors make the extraction of secondary metabolites from source species highly inefficient (Atanasov et al. [@CR10]; Ochoa-Villarreal et al. [@CR116]) and emphasize the need for novel approaches for secondary metabolite production.

The in vitro culture of plant cells and tissues under controlled conditions offers a well-founded technology platform for the production of plant natural products. The in vitro propagation (micropropagation) of plants or the in vitro culture of plant organs (usually roots) or callus can typically provide plant material capable of producing secondary metabolites (Atanasov et al. [@CR10]; Morales-Rubio et al. [@CR107]; Ochoa-Villarreal et al. [@CR116]; Espinosa-Leal et al. [@CR44]). Micropropagation has, therefore, become a commercially lucrative enterprise and provides marked advantages over conventional horticultural propagation practices by facilitating the production of large numbers of homogenous plants year-round, the generation of disease-free propagules and a substantial enhancement of multiplication rates (Debnarh et al. [@CR37]). Currently, a large number of protocols are available for the micropropagation of medicinal plants (Debnarh et al. [@CR37]; Rizvi and Kukreja [@CR141]; Sarasan et al. [@CR149]; Kaul et al. [@CR81]; Kun-Hua et al. [@CR92]; Bhattecheryya et al. [@CR19]; Chen et al. [@CR26]; Atanasov et al. [@CR10]), as well as some commercially important plants, such as *Agave salmiana* (Puente-Garza et al. [@CR131]), artichoke (Pandino et al. [@CR120]), *Stevia rebaudiana* (Ramírez-Mosqueda et al. [@CR137]) and *Moringa oleifera* (drumstick tree) (Juan-jie et al. [@CR78]). However, the high costs of micropropagation compared with its traditional counterpart (i.e., collection from the wild) and the unpredictability of the needs of the market have limited the use of micropropagation at a commercial level (Debnarh et al. [@CR37]; Methora et al. [@CR105]; Lubbe and Verpoorte [@CR100]; Pence [@CR124]; Sahu and Sahu [@CR145]). Notably, however, recent micropropagation efforts have been aimed at the conservation of overexploited medicinal plants, with special emphasis in plants used for traditional medicines in China and India (Rizvi and Kukreja [@CR141]; Verma et al. [@CR130]; Bhattecheryya et al. [@CR19]; Chen et al. [@CR28]).

Recent advances in plant cell culture, brought about by the established experience with microbial and animal cell culture, has resulted in effective scale-up from the experimental stage to an industrial scale. Plant cell culture now represents an efficient way to produce several valuable natural products (Fischer et al. [@CR48]). As shown in Table [1](#Tab1){ref-type="table"}, the range of commercially important products includes pigments (e.g., anthocyanins and betacyanins), anti-inflammatory agents (e.g., berberine and rosmarinic acid), and anti-cancer molecules (e.g., paclitaxel and podophyllotoxin).Table 1List of some secondary metabolites industrially produced by plant tissue culture (with information of Wilson and Roberts [@CR184]; Ochoa-Villarreal et al. [@CR116])Secondary metabolitesPlantType of cultureUseManufacturer/notesAnthocyanins*Euphorbia milii*Cell suspensionTextile dyeColoring agent for beveragesManufactured by Nippon Paint Co., Ltd (Japan)(Yamamoto [@CR186])AnthocyaninsArbutin*Aralia cordata*Cell suspensionTextile dyeColoring agent for beveragesPigmentAnti-septicManufactured by Tonen Co., Ltd (Japan)Sakamoto et al. ([@CR147])Mitsui Chemicals, Inc. (Japan)*Catharanthus roseus*Cell suspensionBerberine*Coptis japonica*Anti-cancerAnti-bioticAnti-inflammatoryMitsui Chemicals, Inc. (Japan)BerberineBetacyanins*Thalictrum minus*Immobilized cell cultureAnti-cancerAnti-bioticAnti-inflammatoryRed to red-violet pigmentFood colorant and dyeMitsui Chemicals, Inc. (Japan)Kobayashi et al. ([@CR86])Nippon Shinyaku Co., Ltd. (Japan)*Beta vulgaris*Carthamin*Carthamus tinctorius*Cell cultureRed pigmentFood colorant and dyeKibun Foods, Inc. (Japan)Saito et al. ([@CR146])Echinacea polysaccharides*Echinacea purpurea*Cell cultureImmunostimulantAnti-inflammatoryDiversa (Germany)Wagner et al. ([@CR178])Geraniol*Geraminea* spp.Anti-inflammatoryEssential oilPrimary component of rose, palmarosa and citronella oilMitsui Chemicals, Inc. (Japan)*Panax ginseng*GinsengWild ginseng stem cellsDietary supplementNitto Denko Corporation (Japan)PaclitaxelTaxus spp.Cell suspensionDietary supplementCosmeticsUnhwa Biotec Corp.Taxus spp.*Podophyllum* spp.Anti-cancerFDA approved for the treatment of ovarian, breast and lung cancersPhyton Biotech, Inc. (USA/Germany)PaclitaxelPodophyllotoxinTaxus spp.*Podophyllum* spp.*Coleus blumei*Cell suspensionAnti-cancerFDA approved for the treatment of ovarian, breast and lung cancersAnti-cancerStarting compound for the anti-cancer agents etoposide and teniposideGenexol^®^---Samyang Genex (Korea)Cell/organLargest application of commercial plant cell cultureNippon Oil (Japan)Giri and Narasu ([@CR56])Rosmarinic acid*Duboisia* spp.Anti-inflammatoryA. Nattermann & Cie. GmbH (Germany)Scopolamine*Lithospermum erythrorhizon*Hairy rootAnti-cholinergicumAnti-muscarinicFor the treatment of motion sickness, nausea and intestinal crampingSumitomo Chemical Co., Ltd. (Japan)Muranaka et al. ([@CR110])Shikonin*Atropa belladonnaCarlina acaulis*Hairy rootsRed pigmentAnti-bioticMitsui Chemicals, Inc. (Japan)Coumarins, flavonoids, alkaloids*Nicotiana glaucaPanax ginseng*Hairy rootsCosmetic active ingredientsRootec, Witterswil, Switzerland

Plant-made pharmaceuticals and other bioengineered products {#Sec4}
-----------------------------------------------------------

In the early 1990s, transgenic plants were endorsed as an alternative means of production of pharmaceutically important proteins. A transgenic system offers several advantages, including decreased costs, increased ease of delivery and scale-up, decreased risk of contamination with animal and human pathogens, and eukaryotic protein processing. Despite the potential of the method, the past 20 years since its introduction have seen transgenic biomolecules (mostly orally delivered, plant-made vaccines) continue to languish in Phase I of human clinical trials. Only in this current decade has a breakthrough been made, and plant-based products are now geared to proceed to Phase II trials and beyond (Pogue et al. [@CR129]; Thomas et al. [@CR166]).

Table [2](#Tab2){ref-type="table"} lists the first plant-made human recombinant therapeutic protein approved by regulatory agencies for commercial sale in 2014. Developed by Pfizer, Inc. and Protalix Biotherapeutics, the enzyme taliglucerase alfa (commercially known as ELELYSO-™) is a treatment for Type 1 Gaucher disease (Pfizer [@CR126]; Pastores et al. [@CR122]). More plant-based products are awaiting approval in one of the phases of clinical trials, and some companies, including Icon Genetics, Ventria Bioscience and Greenovation Biotech, now have the technologies available for the production of several pharmaceuticals derived from plants (see Table [2](#Tab2){ref-type="table"}). This seemingly show growth of the field can be attributed to some of the challenges presented by the method, such as low yields, unwanted glycosylation of products, purification and downstream processing hurdles, and the challenges inherent in the creation of a new manufacturing industry (Tusé et al. [@CR168]; Yao et al. [@CR187]).Table 2List of some pharmaceuticals produced in plantsPlant-made pharmaceuticalPlantUseManufacturer/notesELELYSO™ (taliglucerase alfa)Carrot or tobacco cell cultureEnzyme replacementProtalix, Carmiel, Israel and Pfizer, USAProCellEx^®^ Stable ExpressionFirst plant-made human recombinant therapeutic protein approved (2014)Vaccine (NDV)Tobacco suspension culturesAgainst Newcastle disease virusDow Agrosciences, LLC, Indianapolis, USAFirst tobacco cell-based vaccine approved by the FDA against Newcastle disease virus in poultryVEN150Rice seedsFor HIV-associated chronic inflammationVentria Bioscience, Junction City, KS, USAExpress Tec Stable ExpressionScale CostMoss-GAAMossPompe diseaseGreenovation Biotech GmbH, Heilbronn, GermanyMoss *Physcomitrella patens*-based BroytechnologySpeed Scale and CustomizedMoss-GBAMoss*Nicotiana benthamiana*AlfalfaGaucher's diseaseGreenovation Biotech GmbH, Heilbronn, GermanyMoss *Physcomitrella patens* based BroytechnologySpeed Scale and CustomizedMedicago, Québec, QC, CanadaProficia™ Transient Expression; Stable ExpressionSpeedMoss-AGALFabry diseaseVaccinesInfluenzaRabiesRotavirusAntibodyDuckweed leafy biomassFor non-Hodgkin's lymphomaSynthon, Nijmegen, The NetherlandsLEX system Stable expressionSpeed qualityAntibodyTobacco leavesFor HIVFraunhofer IME, Aachen, GermanyStable Nuclear ExpressionScale CostSerum albuminRice seedHealthgen, Wuhan, Hubei, ChinaStable ExpressionQuality ScaleCaroRxTobacco leavesFor dental cariesPlanetBiotechnology, Hayward, CA, USAStable ExpressionQuality ScalePBI-220Tobacco leavesAntibody for anthraxPlanetBiotechnology, Hayward, CA, USAStable ExpressionQuality ScaleDPP4-FcCoronavirus infectionWith information of Wilson and Roberts ([@CR184]) and Yao et al. ([@CR187])

Some of these problems can be resolved by judicious selection of the plant material. For instance, the use of maize or lettuce, which are both edible and free of harmful substances, can reduce the need for the intensive purification required for the preparation of parenteral pharmaceuticals, thereby reducing the downstream costs (Hayden et al. [@CR67], [@CR68]; Lakshmi et al. [@CR94]; Czyz et al. [@CR35], [@CR36]; Sue et al. 2015). In addition, the appropriate selection of the desired transgenic phenotypes and the use of breeding methods such as backcrossing or inbreeding can lead to the preservation of valuable traits, including high expression of the desired pharmaceutical by the plant material (Pniewski et al. [@CR128]). Other advances have been made in glyco-engineering of host plants, which allows the engineered plants to produce human and mammalian-analogous molecules that exhibit comparable activity to their equivalents produced by mammalian cells in culture (Castilho et al. [@CR24]; Zeitlin et al. [@CR189]; Gleba et al. [@CR57]).

Other plant metabolites of interest, which can be bioengineered, are plant growth regulators. These are typically produced in miniscule quantities in plants, but are essential for the regulation of plant cellular processes (Wani et al. [@CR181]). Growth regulators also have critical roles in controlling plant responses to the abiotic stresses, such as drought, salinity and extreme temperatures, factors that limit crop productivity worldwide (Wani and Sah [@CR180]). Due to these characteristics engineered plant growth regulators can be used for the improvement of crops from both nutritional and stress-resistance perspectives (Wani et al. [@CR181]).

Plants employed for the production of biologically active compounds {#Sec5}
===================================================================

An abundance of options, ranging from model plants and crops to wild-type plants, is available when selecting an appropriate plant material for the production of biomolecules. The selection of which plant to use will depend on a number of factors, with the chief considerations being the purpose of the study and the availability of the plant.

Most plants employed for the production of secondary metabolites are non-crop wild types, since these are the plants that already contain the metabolic tools for synthesis of many metabolites of interest (see Table [1](#Tab1){ref-type="table"}). Some examples include *Agave salmiana* for saponins (Puente-Garza et al. [@CR131]), *Rhaponticoide mykalea* for chlorogenic acids (Hayta et al. [@CR69]) and phenolic compounds (Karalija et al. [@CR79]), *Leucophyllum frutescens* for phenolic compounds (Espinosa-Leal et al. [@CR43]) and *Poliomintha glabrescens* for luteolin (García-Pérez et al. [@CR51]). All of these compounds are useful in the food, pharmaceutical or cosmetic industries (Perassolo et al. [@CR125]). Other crop plants are used for the production of metabolites such as betalains, which are natural colorants as well as good antioxidants. The main sources of betalain metabolites are the cactus pear (*Opuntia ficus*-*indica*) and red beet (*Beta vulgaris*), and these metabolites are typically produced using hairy roots in bioreactors or by callus culture (Georgiev et al. [@CR53]).

Other crop plants, or their parts, that are used for the production of bioengineered compounds, include carrot cells (enzyme replacement), rice (albumin serum) (both presented in Table [2](#Tab2){ref-type="table"}), maize (vaccines, such as anti-HBV) and lettuce (vaccines and antibodies) (Hayden et al. [@CR67], [@CR68]; Lakshmi et al. [@CR94]; Czyz et al. [@CR35], [@CR36]; Su et al. [@CR162]; Yao et al. [@CR187]). Model plants, such as *Nicotiana benthamiana,* are also transformed for the production of plant pharmaceuticals (Yao et al. [@CR187]), as summarized in Table [2](#Tab2){ref-type="table"}.

Methods of plant tissue culture {#Sec6}
===============================

Several methods are available for plant tissue culture; two of the most commonly used are presented in Fig. [1](#Fig1){ref-type="fig"}. Organogenesis, which refers to the production of plant organs (roots or shoots), can be accomplished directly from meristems or indirectly from dedifferentiated cells (callus). The resulting cultures can later be used for the massive production of plants (micropropagation) or for the growth of particular organs (i.e., roots in hairy root culture). Callogenesis produces an amorphous mass of cells in response to exposure of explants to different growth regulators. The callus can then be used to regenerate whole plants, or it can be scaled up for the production of important metabolites in cell suspension cultures (Morales-Rubio et al. [@CR107]).

All plant tissue culture methods follow a series of steps, as mentioned in Table [3](#Tab3){ref-type="table"}. First, the plant of interest needs to be selected; this is generally dependent on the aim of the study, but disease- and insect-free plants are preferred; if the plant requires it, some pre-treatments (fungicides and pesticides) can be applied. The next step is the initiation of the in vitro culture. The process requires the excision of small plant pieces (explants) or the use of seeds and their surface sterilization with chemicals. The explants are then placed in appropriate culture media and incubated for a short period of time; contaminated explants are discarded while the surviving ones continue to the next step. The following steps vary depending on the type of culture desired. In organogenesis, this is the propagation phase when explants are cultured on appropriate culture media for shoot or root multiplication, similarly in callogenesis the callus is multiplied. In the next step, callus and root cultures are scaled up for their culture using bioreactors, while the propagated shoots are transferred to root-promoting culture media, in the case of micropropagation. Finally, the micropropagated plants are hardened to grow individual plants capable of photosynthesis. The hardening is done gradually allowing the plants to acclimate to ex vitro conditions. Typically the plants are taken from high to low humidity and from low to high light intensity (Ahloowalia et al. [@CR4]; Espinosa-Leal et al. [@CR44]).Table 3List of in vitro tissue culture stepsStepNameDescription0Pre-propagationSelection of appropriate plantPre-treatment of plant1InitiationSelection of explants (shoot tip, meristem tip, nodal bud, floral meristem and bud)Surface sterilization (sodium hypochlorite, ethanol, sterile distilled water, detergent)2PropagationMicropropagation: shoot inductionOther: callus of root proliferation3Propagation 2Micropropagation: root inductionOther: scale up to bioreactors4HardeningAcclimation to ex vitro conditionsWith information from Ahloowalia et al. ([@CR4]) and Espinosa-Leal et al. ([@CR44])

The following sections cover novel developments in plant tissue culture that allow a more efficient production of bioactive compounds.

Improvements in traditional culturing techniques {#Sec7}
------------------------------------------------

Micropropagation has been the technique of choice for the production of whole plants for medicinal, conservation, reforestation and commercial purposes (Afolayan and Adebola [@CR2]; Debnarh et al. [@CR37]; Sarasan et al. [@CR149]). Tissue culture of plants capable of producing important biomolecules offers a number of advantages over traditional field culture, including independence from geographical, seasonal, and environmental variations; uninterrupted production in uniform quality and yield; no need for pesticide and herbicide application; and comparatively short growth cycles (Rao and Ravishankar [@CR139]; Debnarh et al. [@CR37]). Production of secondary metabolites by plant tissue culture depends on a number of factors, chief among them are the nutrients provided for plant growth. The optimum nutrient concentration is a critical determinant in the growth of the explants and the accumulation of secondary metabolites (Rao and Ravishankar, [@CR139]; Nagella and Murthy [@CR112]; Murthy et al. [@CR111]; Fargoso Monfort et al. [@CR47]). The type of culture media used, the salt strength of the medium employed and the growth regulators, type and concentration used, are key factors that most be established for every culture (Rao and Ravishankar, [@CR139]; Fargoso Monfort et al. [@CR47]). The concentration of salts present in the culture media needed by a specific plant varies depending on the particular culture needs. The selection of a suitable medium is essential to establish cell and organ cultures (Nagella and Murthy [@CR112]; Fargoso Monfort et al. [@CR47]). Three of the most popular culture media employed are MS, B5 and WPM, as listed in Table [4](#Tab4){ref-type="table"}. MS basal media contains the highest total salts and nitrogen content. Nitrogen is an essential element that promotes explant growth, since it directly affects amino acid and nucleic acid production in the cells. MS basal media (1962) is the most commonly used plant culture media. As presented in Table [4](#Tab4){ref-type="table"}, it has a very high salt content, nevertheless, it is the preferred medium for the growth of several species (Alvarenga et al. [@CR7]; Grzegorczyk-Karolak et al. [@CR61]; Rahman et al. [@CR135]). It has been demonstrated that different MS salt concentrations influence growth in several species (Assis et al. [@CR9]; Martins et al. [@CR104]; Shekhawat et al. [@CR151]; Singh et al. [@CR154]). Generally, lower salt concentrations stimulate rooting (Sorace et al. [@CR157]; Golle et al. [@CR59]; Shekhawat et al. [@CR151]). Fargoso Monfort et al. ([@CR47]) found that in *Ocimum basilicum* volatile constituents diminished with higher salt concentrations. Plant growth regulators can affect the production of secondary metabolites, a recent review by Jamwal et al. ([@CR75]) presents a summary of the production of natural products by using different plant growth regulators.Table 4List of commonly used culture media used for in vitro plant tissue cultureCulture mediaSalt content (g/L)Nitrogen content (mM)WPM2.6814.70B53.2826.75MS4.6360.01With information from Fargoso Monfort et al. ([@CR47])

Nevertheless, one of the principal disadvantages of in vitro tissue culture is the high cost involved with the technique, particularly the expenses associated with culture media (mainly the carbon source, gelling agent and growth regulators), electricity and labor. Some studies have attempted to remedy the cost of culture media using alternative materials, such as household sugar or other sugars, as carbon sources and various types of starches and plant gums instead of agar. Other alternatives have included the use of liquid media and cell-suspension cultures, temporal immersion systems, and reusable glass beads as substitute support matrices (Etienne and Berthouly [@CR45]; Goel et al. [@CR58]; Thorpe [@CR167]; Sahu and Sahu [@CR145]). The cost of electricity can amount up to 60% of tissue culture production costs. The electrical energy is mostly employed for autoclaving, lighting of the growth room and air filtration in laminar-flow cabinets and air conditioning (Ahloowalia and Savangikar [@CR3]; George and Manuel [@CR52]). The use of artificial lighting in growth rooms is the most expensive and inefficient method on tissue culture technology. It generates heat that needs to be dissipated using air conditioning and it does not match natural light. Additionally, even though plants are capable of adapting to an ample range of conditions, once the adaptation occurs, re-adaptation to new conditions is slow and difficult (Ahloowalia and Savangikar [@CR3]; George and Manuel [@CR52]). The use of natural light is a low-cost option for tissue culture, it reduces electricity and capital costs as well as improves plant quality. There are several ways to achieve this, a simple option is to diffuse natural light under plastic or glass, this works best in temperate climates; some laboratories can be modified to adapt the use of 'solatube' which redirects daylight from rooftops through reflecting tubing (Kodym and Zapata-Arias [@CR87], [@CR88]; Kodym et al. [@CR89]; Ahloowalia and Savangikar [@CR3]) some laboratories can incorporate southwest facing windows in the growth rooms that allow for indirect diffused natural daylight, as is the case of bio-factories in Cuba (Baezas-Lopez [@CR11]; Ahloowalia and Savangikar [@CR3]) and finally some cultures have been successfully propagated using plastic bags as culture containers and hanging them in greenhouses thus eliminating the need of air-conditioned growth rooms (Ahloowalia and Savangikar [@CR3]). Temperature regulation, another high electricity demanding feature of plant in vitro culture, can be mostly avoided since many plants can tolerate wide fluctuations in temperature (Kodym et al. [@CR89]). Labor is another source of high in vitro tissue culture costs. Once the efficiency of labor in transferring number of propagules per hour has been achieved to the maximum possible, there is little room for improvement unless an automated or semi-automated system is implemented. For example, the use of bioreactors and mechanized handling of propagules, such systems have shown to reduce the cost of production by 50% (Ahloowalia and Savangikar [@CR3]; George and Manuel [@CR52]).

Another problem found in plant tissue culture involves the genetic stability of the plants. Different cases of micropropagation of in vitro-regenerated plants have shown that they are not always clonal copies of the mother plant (Devi et al. [@CR39]; Bhattacharyya et al. [@CR17]). In vitro culture conditions, especially some growth regulators and elicitors, act as stress factors that induce alterations in sensitive regions of plant genome, and therefore, generate instability in cultured cells, tissues and organs, an occurrence known as somaclonal variation (Larkin and Scowcroft [@CR95]; Gyulai et al. [@CR65]; Bairu et al. [@CR12]; Stanišic et al. [@CR160]; Govindaraju and Arulselvi [@CR60]). The genetic changes experienced by the culture include: alternative DNA methylation, amplification, activation of transposable elements, polyploidy, changes in chromosome number or DNA sequence (Bairu et al. [@CR12]; Stanišic et al. [@CR160]; Govindaraju and Arulselvi [@CR60]). Typically regeneration protocols involving a callus phase are considered the least reliable for clonal propagation, while plantlets regenerated by branching of the axillary buds or direct somatic embryos are considered to be, genetically, the most uniform (Rani and Raina [@CR138]; Varshney et al. [@CR170]; Bhattacharyya et al. [@CR18]). The occurrence of somaclonal variations during in vitro propagation, industrial production of phytochemicals, or genetically engineered plants can lead to massive economic consequences and represents a serious obstacle in the practical utilization of plant tissue culture techniques for the production of active metabolites (Rahman and Rajora [@CR134]; Bhattacharyya et al. [@CR16]). Therefore, to screen somaclonal variability within a cell culture, it is necessary to monitor and assess the genetic constitution and stability of the in vitro-regenerated plants. The methodologies involved in that process include the use of several techniques to assess possible alterations at different levels (Devarumath et al. [@CR38]; Bhattacharyya et al. [@CR15], [@CR17]; Bose et al. [@CR22]; Bhattacharyya and Van Staden [@CR14]). Flow cytometry and chromosome counting are widely used to assess changes in ploidy and chromosome number; PCR-based DNA markers, random amplified polymorphic DNA (RAPD), random fragmented length polymorphism (RFLP), inter simple sequence repeat (ISSR), amplified fragment length polymorphism (AFLP), microsatellite markers, and start codon targeted (ScoT) polymorphism have been successfully used to evaluate genomic stability of regenerated plants (Hu et al. [@CR71]; Collard and Mackill [@CR32]; Bairu et al. [@CR12]; Singh et al. [@CR153]; Bhattacharyya et al. [@CR19], [@CR15]; Rathore et al. [@CR140]; Stanišic et al. [@CR160]; Bose et al. [@CR22]; Govindaraju and Arulselvi [@CR60]). An appropriate combination of two or more markers guarantees reliable and efficient testing of genetic fidelity in plants (Palombi and Damiano [@CR118]; Bhattacharyya et al. [@CR16]).

Cell suspension culture remains the best method for the production of active metabolites, especially natural products, with paclitaxel from *Taxus* spp. being the most prominent example (Atanasov et al. [@CR10]) (Table [1](#Tab1){ref-type="table"}). For the production of cell suspension cultures, the calli are first induced in solid media, the cells are then transferred to liquid media. In small laboratories, the cells are first grown in shaking flasks and later transferred to large-scale liquid-phase bioreactors. There are many different types of reactors including tank reactors, bubble beds and rotary rectors (Furusaki and Takeda [@CR50]). Comprehensive reviews on industrial bioreactors have been published previously and can be consulted for more information on the subject (Su and Lee [@CR161]; Huang and McDonald [@CR72]).

A number of limitations are associated with these methods, when compared with microbial cultures, such as the slow growth rates and low and variable yields of metabolites, and these limitations still restrict the industrial use of plant cell suspension cultures (Kolewe et al. [@CR90]; Kirakosyan et al. [@CR84]). However, the production of important metabolites can be enhanced with modifications to the culture media, such as the addition of elicitors or precursors, or the environmental conditions.

Elicitors stimulate the production of plant natural products that serve as plant defense compounds. Several types of elicitors can increase the secondary metabolite production, including pectin and cellulose (plant cell wall constituents), chitin and glucan (from microorganisms) and salicylic acid and methyl jasmonate (plant immune signaling molecules) (Namdeo [@CR114]; Shilpa et al. [@CR152]; Sharma et al. [@CR150]; Ochoa-Villarreal et al. [@CR116]). Srivastava and Srivastava ([@CR159]) used different fungal culture filtrates as biotic elicitors in root cultures of *Azadirachta indica* to promote the production of Azadirachtin. Filtrates of *Curvularia lunata* yielded the highest production of the target compound compared to control. Saranya Krishnan and Siril ([@CR148]) used yeast extracts, pectin and xylan to elicit the production of anthraquinones in *Oldenlandia umbellate* cultures, with the addition of pectin resulting in the highest elicitation. The selection of the adequate elicitor will depend on the metabolite being produced and the plant culture employed.

Another strategy is to supplement with precursors that are intermediary compounds of the metabolic pathway of the desired natural product. Supplementing the culture media with precursors of secondary metabolites can enhance the yield of the final product (Rao and Ravishankar [@CR139]; Hussain et al. [@CR74]), and has been used successfully in several cases, including the production of phenolic compounds (Palacio et al. [@CR117]), triterpenoids (Chen et al. [@CR29]) and withanolides (Sivanandhan et al. [@CR155]). Cultures of *Antrodia cinnamomea* were fed exogenous sterols including squalene, cholesterol, and stigmasterol to enhance their triterpenoid content, the feeding of high doses of stigmasterol resulted in an increased amount of terpens (Chen et al. [@CR29]). When searching for appropriate precursors it is important to look at the entire biosynthetic pathway and include several molecules involved in different steps of the process, incorporating some examples that affect the production of the target compound in indirect ways. Srivastava and Srivastava ([@CR159]) studied the use of precursors to enhance production of azadirachtin including sodium acetate, cholesterol, squalene, isopentenyl pyrophosphate, and others. They found the best results using cholesterol as an indirect precursor. Parra et al. ([@CR121]), evaluated the effect of different biochemical precursors in fatty acids production in cacao cell cultures including biotin, pyruvate, acetate and bicarbonate, they also utilized glycerol because it is involved in triglycerides assembly. The later was found to induce a higher fat production compared to the other precursors and control. It is also important to remember that the precursor must be easier and cheaper to acquire the compound of interest.

An alternative way of increasing natural product production is by manipulation of environmental factors. Plants are heavily influenced by environmental factors to regulate the biosynthesis of secondary metabolites, through stress response mechanisms (Zhi-lin et al. [@CR191]; Verma and Shukla [@CR171]). Abiotic stresses related to environmental factors include light intensity, water availability, temperature (high or low), radiation (UV), gaseous toxins (ozone), pesticides and metals (Ni, Cd, Co, Fe, Zn) (Ramakrishna and Ravishankar [@CR136]; Raduisene et al. [@CR133]). Water stress is produced when the plant has limited water availability, either because there is no water (drought) or because the water is dissolving a solute (salinity). Drought stress can be induced in vitro by the addition of high-molecular-weight solutes, such as polyethylene glycol (PEG), to the culture media (Verslues et al. [@CR174]). It has been proven to enhance the production of saponins in *A. salmiana* (Puente-Garza et al. [@CR132]), phenolics in *Poliomintha glabrescens* (García-Pérez et al. [@CR51]) and rosmarinic acid in *Salvia miltiorrhiza* (Liu et al. [@CR99]). For the induction of salinity stress different concentrations of salts, such as NaCl and Na~2~CO~3~, can be added to the culture media. This type of stress has resulted in increased production of steviol glycoside content in *Stevia rebaudiana* (Gupta et al. [@CR64]); Sorbito in *Lycopersicon esculentum* (Tari et al. [@CR163]) and flavonoids in *Hordeum vulgare* (Ali and Abbas [@CR5]). Light is an essential abiotic environmental component for plants, since it permits photosynthesis; however, high levels of UV radiation can be harmful (Verma and Shukla [@CR171]). To protect itself form oxidative damage the plant produces several antioxidant metabolites such as polyphenols and tocopherols (Kaur and Kapoor [@CR82]; Argolo et al. [@CR8]). UV radiation can, therefore, be used to enhance the production of secondary metabolites, typically by exposing the cultures to UV light using a special lamp for a set period of time. The technique has been used in *Vitis vinifera* calli to produce flavonols (Cetin [@CR25]). Different chemicals, including heavy metals, can cause chemical stress. Metal ions influence the production of secondary metabolites, and depending on the plant species and heavy metal type and concentration can even enhance their production (Ramakrishna and Ravishankar [@CR136]; Verma and Shukla [@CR171]; Maleki et al. [@CR101]). As an example is the case of *Thalictrum rugosum* cell suspension culture that used CuSO~4~ to stimulate the production of berberine (Kim et al. [@CR83]).

These improvements, however, are not sufficient to sustain an adequate large-scale production of bioactive compounds, so other methods are still needed.

Alternatives to in vitro plant culture {#Sec8}
--------------------------------------

The low yield of secondary metabolites in cell cultures can be explained as a consequence of a lack of cell differentiation. An alternative strategy to cell culture is the organized culture of roots or shoots (Verporte et al. 2002; Kolewe et al. [@CR90]). Hairy root culture is a perfect example; it is induced by infection of roots with *Agrobacterium rhizogenes* and the subsequent transfer of the Ri plasmid, which induces abundant growth of neoplastic roots that can be maintained in vitro (Ron et al. [@CR143]). Grzegorczyk-Karolak et al. ([@CR62]) obtained hairy root culture of *Salvia viridis* by wounding shoot explants with needles dipped in *Agrobacterium rhizogenes* strain A4 culture. Some of the advantages provided by hairy root cultures include high growth rates without the need for plant growth regulators, genetically and biochemically stable cultures, and a similar capacity for production of secondary metabolites than cell suspension cultures (Guillon et al. [@CR63]; Georgiev et al. [@CR55]; Mora-Pale et al. [@CR108]). A wide range of natural products has been produced using this system, including lignans, steroids, anthraquinones and alkaloids (Doma et al. [@CR41]; Huang et al. [@CR73]; Pandey et al. [@CR119]; Wawrosch et al. [@CR182]). However, metabolite production requires that the compound of interest be one that is normally synthesized within the roots of the source plant, so this limits the versatility of the hairy root system (Ochoa-Villarreal et al. [@CR116]).

Nevertheless, the greatest limiting factor in the industrial use of hairy rots for the production of secondary metabolites is their scale-up, since it requires the development of appropriate culture vessels that permit mixing without causing shear damage to the interconnected root mat. Binoy et al. ([@CR20]) designed a novel culture vessel by customizing a reaction kettle (2 L) for the culture of *Plumbago rosea* and production of plumbagin an anticancer molecule. Srivastava and Srivastava ([@CR158]) described the different configurations and parameters of bioreactors for hairy roots culture, which include liquid phase, gas phase and hybrid systems. ROOT Bioactives AG, a Swiss company, has successfully developed and optimized a bioreactor system for large-scale cultivation of hairy roots capable of producing many kinds of bioactive compounds, including secondary metabolites and recombinant glycosylated proteins with pharmaceutical properties (Atanasov et al. [@CR10]; Ochoa-Villarreal et al. [@CR116]). However, many factors influence the scale-up process, such as culture medium properties, hormonal balance, gaseous composition, growth kinetics, inoculum density, culture period, and the species (Ho et al. [@CR70]). In the scale-up process, Ho et al. ([@CR70]) recently obtained a 4.01-kg dry root biomass with a yield of 287.12 mg/L of total phenolic productivity for *Polygonum multiflorum* in a 500 L pilot-scale reactor. Hybrid systems, which include a liquid- and a gas phase, are reactors that attend the disadvantage of the null distribution uniformity of cells in gas-phase reactors, and the limitations of the mass transfer in liquid-phase reactors; these systems offer the best compromise between the two systems, used in alternate way (Srivastava and Srivastava [@CR158]). Biomass measurement is one of the major challenges during scale-up of hairy roots culture, however, it is also important to determine the harvest capacity of secondary metabolites and their bioactivity, some examples are phenolic compounds (Ho et al. [@CR70]; Thiruvengadam et al. [@CR165]), xanthones (Vinterhalter et al. [@CR175]), glucosinolates (Chung et al. [@CR31]), tetraterpenoids (Thakore and Srivastava [@CR164]), among others.

Transformed hairy roots have shown a higher biological activity, compared with non-transformed roots (Chung et al. [@CR31]; Jeong et al. [@CR77]; Vinterhalter et al. [@CR175]). However, it is important to determine the optimal number of subcultures to avoid somaclonal variations that can affect the yield and behavior of plant cell cultures (Martínez-Estrada et al. [@CR103]). Additionally, hairy root culture is susceptible to the use of biotic and abiotic elicitors to enhance the production of the desired metabolites, like the examples presented above from Srivastava and Strivastava (Srivastava and Srivastava [@CR159]). Furthermore, a combined approach using both types of elicitors can be employed. For instance Wang et al. ([@CR179]) used ultraviolet-B (UV-B) radiation and methyl jasmonate applied alone or in combination in *Salvia miltiorrhiza* hairy root cultures and found that the combined treatment exhibited synergistic effects on the expression levels of genes in the tanshinone biosynthetic pathway.

Another way to avoid some of the major difficulties encountered when using cell cultures, such as variability in product biosynthesis, large cell aggregates and shear stress (Yun et al. [@CR188]), is to use cultures of undifferentiated cambial meristematic cells. These cultures are not only free of the problems stated above, but the cells are physiologically stable and show high growth rates (Lee et al. [@CR96]; Jang et al. [@CR76]). Cambial meristematic cells are undifferentiated cells that grow indefinitely, behaving like plant stem cells (Lee et al. [@CR96]; Ochoa-Villarreal et al. [@CR116]). They eliminate the need for dedifferentiating plant cells for the establishment of plant cell cultures, and they offer greater stability in product accumulation over long periods (Lee et al. [@CR96]). This type of culture has been established for the production of nutritional, cosmetic and medicinal products and is currently considered a key platform for the large-scale production of natural products (Roberts and Kolewe [@CR142]; Yun et al. [@CR188]; Ochoa-Villarreal et al. [@CR116]).

Plant cell cultures rarely present uniform physiological characteristics, most especially callus cultures. Their heterogeneous nature results in the need to select highly productive cell lines to establish profitable production platforms for natural products (Mulabagal and Tsay [@CR109]; Ochoa-Villarreal et al. [@CR116]). A novel cell line can be obtained by employing cell-cloning methods. First, since accumulation of active metabolites is genotype specific, an appropriate selection of suitable species and later organs for callus production is needed (Murthy et al. [@CR111]; Ochoa-Villarreal et al. [@CR116]). The selection process depends on the type of compound intended to produce, if the product of interest is a pigment a spectrophotometric method can be employed, however, if it is not other chemical-based approaches are needed (Fujita et al. [@CR49]; Mulabagal and Tsay [@CR109]; Ochoa-Villarreal et al. [@CR116]). A popular method involves the identification of cell lines that exhibit a high level of metabolic flux through the targeted pathway by the exogenous application of an intermediate (Ochoa-Villarreal et al. [@CR116]). For example, high producing shoots of *Mentha arvensis* were screened by adding menthol to the culture media. The surviving clones exhibited high menthol tolerance, thus presenting genotypes capable of elevated menthol production (Dhawan et al. [@CR40]). Nevertheless, the prolonged use of selected natural product producing cell lines is limited, since they often loose their ability to produce the desired metabolites (Georgiev et al. [@CR54]; Wilson and Roberts [@CR184]; Ochoa-Villarreal et al. [@CR116]). The cell lines decrease or loss of active compound biosynthesis is due, in most cases, to genetic instability resulting from somaclonal variations (Ochoa-Villarreal et al. [@CR116]).

Despite the problems presented above, there are some commercially available plant cell lines currently in the market. The most popular is Tobacco Bright Yellow-2 cells (BY-2), they are attractive because of their fast growth rate and their ease of *Agrobacterium*-mediated transformation and cell cycle synchronization (Su and Lee [@CR161]). Additionally, the Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures have an ample catalog of plant cell lines. They offer 41-plant cell lines, 18 of which are delivered as actively growing cultures and 23 are maintained as cryopreserved cultures. Among the plants offered are some model plants like *Solanum tuberosum* and *Arabidopsis thaliana* and some medicinal plants like *Echinacea angustifolia, Arnica montana* and *Valeriana officinalis* (Leibniz Gemeinschaft [@CR97]). Acquisition of the cell lines would facilitate the establishment of the culture and allow for a more streamline process of plant transformation and metabolite production.

Strategies for the expression of plant biologically active compounds {#Sec9}
====================================================================

Low expression levels of plant active metabolites and expression of new important compounds not typically expressed in plants, such as vaccines, create a need for tools that allow the modification of plant genetic material. Plant genetic engineering has been practiced since the 1980s, first with *Agrobacterium* and later with transformation mediated by particle bombardment. Both techniques have been effective for an array of plants, allowing over-expression of secondary metabolites or the production of plant-made pharmaceuticals. Nevertheless, despite this success, these methods present several challenges that limit their use in many crops (Altpeter et al. [@CR6]).

*Agrobacterium*-mediated transformation can be performed in most dicotyledonous (dicot) plants (however, it is mostly limited to some genotypes within a species) and in a small number of monocotyledonous (monocot) plants (Klee et al. [@CR85]; Nam et al. [@CR113]). Problems arising from the use of *A. tumefaciens* for plant transformation include difficulties obtaining licensing (Chi-Ham et al. [@CR30]), high costs of securing regulatory approval, and plant innate responses to bacterial infection, such as the activation of some proteins that cause tissue browning and necrosis that, in turn, reduce transformation frequencies (Altpeter et al. [@CR6]). Some of these difficulties can be easily avoided with small modifications to the technique, like downregulating infection-responsive genes in the host plants or adding antioxidants to the infection medium (Altpeter et al. [@CR6]).

To eliminate the rest of the problems, researchers continue to seek out a novel gene delivery system based on a non-pathogenic organism that will provide high rates of transformation for both dicot and monocot species. Advances have been made with several species of *Rhizobium* (*Sinorhizobium meliloti, Mesorhizobium loti* and NGR 234) known as Transbacter (Zuniga-Soto et al. [@CR194]). Another gram-negative bacterial member of the *Rhizobiaceae* family, *Ensifer adhaerens* strain OV14, unlike *A. tumefaciens,* also seems to be beneficial to plants and has been used successfully for the transformation of *Arabidopsis thaliana, Solanum tuberosum* and *Oryza sativa* L. (Martin [@CR102]; Wendt et al. [@CR183]; Zhou et al. [@CR192]).

Bioballistics can be used on a wider range of plant genotypes than are amenable to *Agrobacterium* transformation. This technique lacks the pathogenic characteristic of the bacteria and simplifies the cloning process since it does not require a specific vector (Chen et al. [@CR27]; Altpeter et al. [@CR6]). However, plant tissues subjected to this technique often show difficulties in regeneration after bombardment and in the transgene performance. The effectiveness seems to depend on particle characteristics, such as type, size, quantity and acceleration; on the DNA amount and structure; and on the tissue type and pretreatment (Zuniga-Soto et al. [@CR194]). Advancements in these techniques could potentially enhance the regeneration and transformation responses of a wide range of plants of economic interest (Zuniga-Soto et al. [@CR194]).

Genome editing mediated by CRISPR/Cas9, a new development in plant genome transformation, may be a promising solution to most of the problems of the currently available techniques. This new technology allows modification of specific areas of the genome with an increased precision of the insertion, while preventing cell toxicity and offering perfect reproducibility (Voytas [@CR176]; Voytas and Gao [@CR177]). Genome editing is currently applied in one of three forms: (1) Alteration of a small number of nucleotides, (2) replacement of an allele with a pre-existing one, and (3) insertion of new genes in predetermined regions of the genome (Abdallah et al. [@CR1]). Since genome editing techniques create only small traces of DNA alterations, most regulatory procedures associated with transgenic plants are avoided and the technique can be employed for the rapid creation of new crops with pest resistance, enhanced nutritional value and drought tolerance (Voytas [@CR176]; Abdallah et al. [@CR1]; Li et al. [@CR98]). Some successful examples include transformations of solanaceous crop plants like potato and tomato (Van Eck [@CR169]), soybean (Li et al. [@CR98]) and some cereals, such as barley, maize, rice, wheat and sorghum (Zhu et al. [@CR193]).

Perspectives for plant production of bioactive molecules {#Sec10}
========================================================

In vitro tissue culture is a vital tool that can be employed for the rapid production of important metabolites. Once a commercially important compound has been identified and isolated, measures can be taken for its scale-up production, as shown in Fig. [1](#Fig1){ref-type="fig"}. Currently, several systems, such as suspension cultures and hairy roots, allow for the large-scale manufacture of plant compounds (Fig. [1](#Fig1){ref-type="fig"}) (Xu et al. [@CR185]). Nevertheless, as mentioned earlier, the high costs associated with this technology makes it uncompetitive when compared to less expensive but environmentally unsustainable processes such as collection of wild plants or when compared to chemical synthesis. These culture methods also still require the use of sterilizable bioreactors, so their scale-up is limited (Nogueira et al. [@CR115]; Buyel et al. [@CR23]).

The advent of novel molecular tools now presents new possibilities for the production of important metabolites using plant systems. Chief among these is the use of targeted genome engineering, particularly the previously mentioned genome editing mediated by CRISPR/Cas9. The use of this technological approach creates the possibility of producing new plant varieties without the introduction of foreign genes (Doudna and Charpentier [@CR42]; Baltes and Voytas [@CR13]; Nogueira et al. [@CR115]). Gene editing could potentially be used for the introduction of new alleles, promoter replacement or the introduction of new pathways, all of which could result in the creation of plant-based systems capable of novel expression of useful bioactive molecules (Nogueira et al. [@CR115]).

Once the plant has been engineered (either by gene editing by CRISPR/Cas9 or by traditional methods), and has passed through in vitro culture, the genetic material can be stored using master and working seed banks (Sack et al. [@CR144]). The plants can then be used for the large-scale production of the desired metabolites, including plant-made pharmaceuticals. Three options are available for the cultivation of the engineered plants: under open-field conditions, if legal, in conventional greenhouses or in vertical farming units, as modeled in Fig. [1](#Fig1){ref-type="fig"}, with the latter two offering ease of scale-up and appropriate containment of the plants (Buyel et al. [@CR23]).

Some plants, like medicinal plants, benefit from in vitro conditions (faster growth rates) and should, therefore, be sustained in those settings (Rao and Ravishankar [@CR139]). With this in mind, several actions can increase the production of secondary metabolites by plant cells (Fig. [1](#Fig1){ref-type="fig"}); some of these, like the use of precursors and elicitors, have already been mentioned. The manipulation of environmental factors, including high/low temperature, drought, UV, alkalinity, salinity, exposure to heavy metals, and others, is now emphasized. These conditions, which are potentially damaging to the plants, often increase the capacity for production or even induce de novo synthesis of secondary metabolites in plant in vitro cultures (Korkina et al. [@CR91]; Lajayer et al. [@CR93]; Moon et al. [@CR106]; Puente-Garza et al. [@CR132]).

Conclusions {#Sec11}
===========

The use of in vitro tissue culture remains a feasible strategy for the production of structurally complex and high-value natural products, especially if the plant source material is an overexploited, slow-growing or low-yielding plant. However, due to the higher costs, a cost--benefit analysis of in vitro culture is wise before implementation of the technique. Similarly, the production of pharmaceuticals using plant culture systems can offer significant advantages, including reduction in costs, rapid production, low burden of human pathogens and scalability; all these advantages are plant product specific and depend on the production efficiencies compared to those offered by alternative sources. In the next decade, tissue culture should reach its full potential with the use of novel technologies such as gene editing and environmental factor manipulation.
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